Toll Free: 1-888-928-9744
Published: Sep, 2016 | Pages:
39 | Publisher: Global Markets Direct
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)
JW Pharmaceutical Corporation - Product Pipeline Review - 2016 Summary Global Markets Direct's, 'JW Pharmaceutical Corporation - Product Pipeline Review - 2016', provides an overview of the JW Pharmaceutical Corporation's pharmaceutical research and development focus. The report provides comprehensive information on the therapeutics under development by JW Pharmaceutical Corporation, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis. The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data. Scope - The report provides a snapshot of the pipeline therapeutic landscape of JW Pharmaceutical Corporation - The report provides overview of JW Pharmaceutical Corporation including its business description, key facts, and locations and subsidiaries - The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities - The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages - The report assesses JW Pharmaceutical Corporation's pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type - The report features JW Pharmaceutical Corporation's out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects Reasons To Buy - Evaluate JW Pharmaceutical Corporation's strategic position with total access to detailed information on its product pipeline - Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Identify and understand important and diverse types of therapeutics under development for JW Pharmaceutical Corporation - Identify potential new clients or partners in the target demographic - Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics - Devise corrective measures for pipeline projects by understanding JW Pharmaceutical Corporation's pipeline depth and focus of pipeline therapeutics - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
Table of Contents Table of Contents 2 List of Tables 4 List of Figures 4 JW Pharmaceutical Corporation Snapshot 5 JW Pharmaceutical Corporation Overview 5 Key Facts 5 JW Pharmaceutical Corporation - Research and Development Overview 6 Key Therapeutic Areas 6 JW Pharmaceutical Corporation - Pipeline Review 9 Pipeline Products by Stage of Development 9 Pipeline Products - Monotherapy 10 Pipeline Products - Combination Treatment Modalities 11 Pipeline Products - Partnered Products 12 Partnered Products/Combination Treatment Modalities 13 JW Pharmaceutical Corporation - Pipeline Products Glance 14 JW Pharmaceutical Corporation - Late Stage Pipeline Products 14 Phase III Products/Combination Treatment Modalities 14 JW Pharmaceutical Corporation - Clinical Stage Pipeline Products 15 Phase I Products/Combination Treatment Modalities 15 JW Pharmaceutical Corporation - Early Stage Pipeline Products 16 Preclinical Products/Combination Treatment Modalities 16 Discovery Products/Combination Treatment Modalities 17 JW Pharmaceutical Corporation - Drug Profiles 18 (pitavastatin + valsartan) - Drug Profile 18 Product Description 18 Mechanism Of Action 18 R&D Progress 18 CW-108F - Drug Profile 19 Product Description 19 Mechanism Of Action 19 R&D Progress 19 CWF-0701 - Drug Profile 20 Product Description 20 Mechanism Of Action 20 R&D Progress 20 CWF-0771 - Drug Profile 21 Product Description 21 Mechanism Of Action 21 R&D Progress 21 CWF-07pre03 - Drug Profile 22 Product Description 22 Mechanism Of Action 22 R&D Progress 22 CWF-0808 - Drug Profile 23 Product Description 23 Mechanism Of Action 23 R&D Progress 23 CWF-09pre02 - Drug Profile 24 Product Description 24 Mechanism Of Action 24 R&D Progress 24 CWP-232228 - Drug Profile 25 Product Description 25 Mechanism Of Action 25 R&D Progress 25 CWP-291 - Drug Profile 26 Product Description 26 Mechanism Of Action 26 R&D Progress 26 docetaxel - Drug Profile 27 Product Description 27 Mechanism Of Action 27 R&D Progress 27 JWF-1103 - Drug Profile 28 Product Description 28 Mechanism Of Action 28 R&D Progress 28 JWF-1201 - Drug Profile 29 Product Description 29 Mechanism Of Action 29 R&D Progress 29 JW Pharmaceutical Corporation - Pipeline Analysis 30 JW Pharmaceutical Corporation - Pipeline Products by Target 30 JW Pharmaceutical Corporation - Pipeline Products by Route of Administration 32 JW Pharmaceutical Corporation - Pipeline Products by Molecule Type 33 JW Pharmaceutical Corporation - Pipeline Products by Mechanism of Action 34 JW Pharmaceutical Corporation - Dormant Projects 36 JW Pharmaceutical Corporation - Locations And Subsidiaries 37 Head Office 37 Appendix 38 Methodology 38 Coverage 38 Secondary Research 38 Primary Research 38 Expert Panel Validation 38 Contact Us 38 Disclaimer 3
List of Tables JW Pharmaceutical Corporation, Key Facts 5 JW Pharmaceutical Corporation - Pipeline by Indication, 2016 8 JW Pharmaceutical Corporation - Pipeline by Stage of Development, 2016 9 JW Pharmaceutical Corporation - Monotherapy Products in Pipeline, 2016 10 JW Pharmaceutical Corporation - Combination Treatment Modalities in Pipeline, 2016 11 JW Pharmaceutical Corporation - Partnered Products in Pipeline, 2016 12 JW Pharmaceutical Corporation - Partnered Products/ Combination Treatment Modalities, 2016 13 JW Pharmaceutical Corporation - Phase III, 2016 14 JW Pharmaceutical Corporation - Phase I, 2016 15 JW Pharmaceutical Corporation - Preclinical, 2016 16 JW Pharmaceutical Corporation - Discovery, 2016 17 JW Pharmaceutical Corporation - Pipeline by Target, 2016 31 JW Pharmaceutical Corporation - Pipeline by Route of Administration, 2016 32 JW Pharmaceutical Corporation - Pipeline by Molecule Type, 2016 33 JW Pharmaceutical Corporation - Pipeline Products by Mechanism of Action, 2016 35 JW Pharmaceutical Corporation - Dormant Developmental Projects,2016 36
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.